
Opinion|Videos|March 21, 2025
Selecting the Best Treatment Options for Patients With Parkinson Disease
Author(s)Daniel E. Kremens, MD, JD
An expert discusses how patients with dyskinesia are well suited to use pumps and how subcutaneous dopamine agonists avoid the issues previously associated with oral dopamine agonists.
Advertisement
Episodes in this series

Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Understanding Key Clinical and Genetic Biomarkers in Huntington Disease Research: Sarah O'Shea, MD, MSc
2
De-Escalation Strategies in Multiple Sclerosis: Oral Therapies and Cladribine
3
Early Results Show Symptom Gains in First Patient Dosed With UX-DA001 Cell Therapy for Parkinson Disease
4
Bringing Biomarkers to the Bedside: The Clinical Promise of Abbott’s TBI Test
5